| Edward's Home Health & Hospice | |
| 1106 Clayton Lane Suite 218e, Austin, Texas 78723 | |
| (512) 763-4690 | |
| Name | Edward's Home Health & Hospice |
|---|---|
| Location | 1106 Clayton Lane Suite 218e, Austin, Texas |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 747789 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 76537, 78602, 78612, 78617, 78621, 78626, 78628, 78660, 78664, 78666, 78681, 78701, 78702, 78704, 78721, 78723, 78724, 78725, 78728, 78735, 78741, 78744, 78745, 78747, 78748, 78752, 78753, 78754, 78757 |
| NPI Number | 1831458249 |
| Organization Name | EDWARD'S HOME HEALTH, INC. |
| Doing Business As | EDWARD'S HOME HEALTH & HOSPICE |
| Address | 8411 N Ih 35, Austin, TX 78753 |
| Phone Number | 512-763-4690 |
News Archive
The Financial Times contrasts the model of drug development for developing countries being used by non-profit groups like the Meningitis Vaccine Project (MVP), which recently rolled out the MenAfriVac, to that of some pharmaceutical companies.
In human relationships, a certain "spark" often governs whether we prefer one person to another, and critical first impressions can occur within seconds.
The state plans to expand its Medicaid program as much as the federal health law envisions, without spending any extra money to make it happen.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, run in centers in Australia and New Zealand, will investigate the antiviral effect of clemizole monotherapy in the absence of interferon.
Inverness Medical Innovations, Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has entered into a binding agreement with Kroll Inc., a subsidiary of Marsh and McLennan Companies, Inc. to purchase its Substance Abuse Testing division (Kroll Laboratory Specialists, Inc.), its business unit providing forensic quality substance abuse testing products and services across the United States.
› Verified 4 days ago
| NPI Number | 1992973028 |
| Organization Name | ELITE NDEPENDENT HOMECARE INC. |
| Address | 1106 Clayton Ln, Suite #554 W, Austin, TX 78723 |
| Phone Number | 713-494-8902 |
News Archive
The Financial Times contrasts the model of drug development for developing countries being used by non-profit groups like the Meningitis Vaccine Project (MVP), which recently rolled out the MenAfriVac, to that of some pharmaceutical companies.
In human relationships, a certain "spark" often governs whether we prefer one person to another, and critical first impressions can occur within seconds.
The state plans to expand its Medicaid program as much as the federal health law envisions, without spending any extra money to make it happen.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, run in centers in Australia and New Zealand, will investigate the antiviral effect of clemizole monotherapy in the absence of interferon.
Inverness Medical Innovations, Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has entered into a binding agreement with Kroll Inc., a subsidiary of Marsh and McLennan Companies, Inc. to purchase its Substance Abuse Testing division (Kroll Laboratory Specialists, Inc.), its business unit providing forensic quality substance abuse testing products and services across the United States.
› Verified 4 days ago
| Quality Rating: |
News Archive
The Financial Times contrasts the model of drug development for developing countries being used by non-profit groups like the Meningitis Vaccine Project (MVP), which recently rolled out the MenAfriVac, to that of some pharmaceutical companies.
In human relationships, a certain "spark" often governs whether we prefer one person to another, and critical first impressions can occur within seconds.
The state plans to expand its Medicaid program as much as the federal health law envisions, without spending any extra money to make it happen.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, run in centers in Australia and New Zealand, will investigate the antiviral effect of clemizole monotherapy in the absence of interferon.
Inverness Medical Innovations, Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has entered into a binding agreement with Kroll Inc., a subsidiary of Marsh and McLennan Companies, Inc. to purchase its Substance Abuse Testing division (Kroll Laboratory Specialists, Inc.), its business unit providing forensic quality substance abuse testing products and services across the United States.
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 99.3 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 89.1 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 100 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 83.5 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 91.2 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.7 | 96.4 |
News Archive
The Financial Times contrasts the model of drug development for developing countries being used by non-profit groups like the Meningitis Vaccine Project (MVP), which recently rolled out the MenAfriVac, to that of some pharmaceutical companies.
In human relationships, a certain "spark" often governs whether we prefer one person to another, and critical first impressions can occur within seconds.
The state plans to expand its Medicaid program as much as the federal health law envisions, without spending any extra money to make it happen.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, run in centers in Australia and New Zealand, will investigate the antiviral effect of clemizole monotherapy in the absence of interferon.
Inverness Medical Innovations, Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has entered into a binding agreement with Kroll Inc., a subsidiary of Marsh and McLennan Companies, Inc. to purchase its Substance Abuse Testing division (Kroll Laboratory Specialists, Inc.), its business unit providing forensic quality substance abuse testing products and services across the United States.
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 86 | 79.6 |
| How often patients got better at getting in and out of bed | 74.6 | 81.1 |
| How often patients got better at bathing | 94.9 | 82.3 |
| How often patients’ breathing improved | 89.2 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 81.7 | 75 |
| How often home health patients had to be admitted to the hospital | 17.6 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 11.5 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 93.9 | 94 |
News Archive
The Financial Times contrasts the model of drug development for developing countries being used by non-profit groups like the Meningitis Vaccine Project (MVP), which recently rolled out the MenAfriVac, to that of some pharmaceutical companies.
In human relationships, a certain "spark" often governs whether we prefer one person to another, and critical first impressions can occur within seconds.
The state plans to expand its Medicaid program as much as the federal health law envisions, without spending any extra money to make it happen.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, run in centers in Australia and New Zealand, will investigate the antiviral effect of clemizole monotherapy in the absence of interferon.
Inverness Medical Innovations, Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has entered into a binding agreement with Kroll Inc., a subsidiary of Marsh and McLennan Companies, Inc. to purchase its Substance Abuse Testing division (Kroll Laboratory Specialists, Inc.), its business unit providing forensic quality substance abuse testing products and services across the United States.
› Verified 4 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | Not Available |
| Health team communicated well with them | Not Available |
| Health team discussed medicines, pain, and home safety | Not Available |
| How patients rated overall care from agency | Not Available |
News Archive
The Financial Times contrasts the model of drug development for developing countries being used by non-profit groups like the Meningitis Vaccine Project (MVP), which recently rolled out the MenAfriVac, to that of some pharmaceutical companies.
In human relationships, a certain "spark" often governs whether we prefer one person to another, and critical first impressions can occur within seconds.
The state plans to expand its Medicaid program as much as the federal health law envisions, without spending any extra money to make it happen.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, run in centers in Australia and New Zealand, will investigate the antiviral effect of clemizole monotherapy in the absence of interferon.
Inverness Medical Innovations, Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has entered into a binding agreement with Kroll Inc., a subsidiary of Marsh and McLennan Companies, Inc. to purchase its Substance Abuse Testing division (Kroll Laboratory Specialists, Inc.), its business unit providing forensic quality substance abuse testing products and services across the United States.
› Verified 4 days ago
The patient survey data of Edward's Home Health & Hospice is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 89 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 80 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 75 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 80 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 69 | 78 |
News Archive
The Financial Times contrasts the model of drug development for developing countries being used by non-profit groups like the Meningitis Vaccine Project (MVP), which recently rolled out the MenAfriVac, to that of some pharmaceutical companies.
In human relationships, a certain "spark" often governs whether we prefer one person to another, and critical first impressions can occur within seconds.
The state plans to expand its Medicaid program as much as the federal health law envisions, without spending any extra money to make it happen.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, run in centers in Australia and New Zealand, will investigate the antiviral effect of clemizole monotherapy in the absence of interferon.
Inverness Medical Innovations, Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has entered into a binding agreement with Kroll Inc., a subsidiary of Marsh and McLennan Companies, Inc. to purchase its Substance Abuse Testing division (Kroll Laboratory Specialists, Inc.), its business unit providing forensic quality substance abuse testing products and services across the United States.
› Verified 4 days ago
Hana Care Texas Location: 223 W Anderson Lane Suite A110, Austin, Texas 78752 Ratings: Phone: (512) 284-7757 | |
Girling Home Health Location: 8701 N Mopac Expressway Suite 165, Austin, Texas 78759 Ratings: Phone: (512) 342-0331 | |
Interim Healthcare Of Austin Location: 505 East Huntland Dr Ste 180, Austin, Texas 78752 Ratings: Phone: (512) 454-5711 | |
Bellcoa Home Health Service Inc Location: 7801 N Lamar Blvd Suite D-79, Austin, Texas 78752 Ratings: Phone: (512) 533-9990 | |
Carter Healthcare Location: 7600 Chevy Chase Drive Bldg 2 Suite 300, Austin, Texas 78752 Ratings: Phone: (830) 625-4837 | |
C C Home Health Central Inc Location: 6633 Hwy 290 East Suite #110, Austin, Texas 78723 Ratings: Phone: (512) 419-7738 |